IP Library › Granted Patent US 7,375,236
Granted Patent B2
US 7,375,236 · App. 11/208,289 · Granted May 20, 2008

Methods for producing cyclic benzamidine derivatives

Assignee: Eisai Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,375,236
App. No.
11/208,289
Granted
May 20, 2008
Kind
B2
Abstract

In the present invention, the methods of producing a fluorinated cyclic benzamidine derivative (A), or a salt thereof, comprise the step of reacting a specific novel compound with ammonia or imide. The methods of this invention for producing a morpholine-substituted phenacyl derivative (B), or a salt thereof, comprise reaction of a specific novel compound with morpholine, reaction of the product with a halogenating reagent, and deketalization of the product. The methods of this invention for a producing cyclic benzamidine derivative (C), or a salt thereof, comprise the step of coupling compound (A), or a salt thereof, with compound (B), or a salt thereof, in the presence of an ether or a hydrocarbon. The methods of this invention for recrystallizing a cyclic benzamidine derivative (C), or a salt thereof, comprise the steps of dissolving compound (C), or the salt thereof, in a mixed solvent comprising an alcohol and water, or a mixed solvent comprising an ether and water, and after dissolution, adding additional water to precipitate crystals of compound (C), or the salt thereof.

Claims (60)

1. A method for producing a fluorinated cyclic benzamidine derivative (A) represented by formula (II) (wherein Et represents an ethyl group), or a salt thereof,

wherein the method comprises the step of reacting a compound represented by formula (I)

(wherein, X represents a leaving group) with ammonia or an imide.

2. The method of claim 1 , comprising the step of reacting the compound represented by formula (I) in which X is —OSO 2 R 1 (wherein, R 1 represents a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 6-10 aryl group, or a halogenated C 6-10 aryl group) with ammonia.

3. The method of claim 1 , comprising the steps of:

(a) reacting the compound represented by formula (I) in which X is —OSO 2 R 1 (wherein, R 1 represents a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 6-10 aryl group, or a halogenated C 6-10 aryl group), with a phthalimide or a succinimide, or a metal salt thereof, and

(b) converting the compound obtained in step (a) into an amine derivative.

4. The method of claim 1 , comprising the step of reacting the compound represented by formula (I) in which X represents a halogen atom, with ammonia.

5. The method of claim 1 , comprising the steps of:

(a) reacting the compound represented by formula (I) in which X represents a halogen atom, with a phthalimide or a succinimide, or a metal salt thereof, and

(b) converting the compound obtained in step (a) into an amine derivative.

6. The method of claim 2 or 3 , wherein a compound represented by formula (I′)

(wherein, R 1 represents a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 6-10 aryl group, or a halogenated C 6-10 aryl group) is obtained by reacting a compound represented by formula (III)

(wherein, Et represents an ethyl group), with R 1 SO 2 Y or (R 1 SO 2 ) 2 O (wherein, R 1 represents a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 6-10 aryl group, or a halogenated C 6-10 aryl group, and Y represents a halogen atom).

7. The method of claim 4 or 5 , wherein the compound represented by formula (I″)

(wherein, Hal represents a halogen atom) is obtained by reacting a compound represented by formula (III)

(wherein, Et represents an ethyl group) with a halogenating reagent.

8. The method of claim 4 or 5 , wherein the compound represented by formula (I″)

(wherein, Hal represents a halogen atom), is obtained by reacting a compound represented by formula (IV)

(wherein, Et represents an ethyl group), with a halogenating reagent.

9. The method of claim 6 , wherein the compound represented by formula (III) is obtained by steps comprising the following (1) to (3):

(1) reacting a compound represented by formula (V)

(wherein, Hal′ represents a halogen atom) with a cyanation reagent to obtain a compound represented by formula (VI)

(2) obtaining a compound represented by formula (VII)

through a formylation reaction of the compound represented by formula (VI); and

(3) obtaining the compound represented by formula (III)

(wherein, Et represents an ethyl group) by reducing the compound represented by formula (VII).

10. The method of claim 4 or 5 , wherein the compound represented by formula (I″)

(wherein, Hal represents a halogen atom) is obtained by steps (1′) to (3′) described below:

(1′) reacting a compound represented by formula (V)

(wherein, Hal′ represents a halogen atom) with a cyanation reagent to obtain a compound represented by formula (VI)

(2′) obtaining the compound represented by formula (IV)

through a methylation reaction of the compound represented by formula (VI); and

(3′) obtaining the compound represented by formula (I″) (wherein Et represents an ethyl group) by reacting the compound represented by formula (IV) with a halogenating reagent.

11. A method for producing a morpholine-substituted phenacyl derivative (B) represented by formula (VIII)

(wherein, Hal″ represents a halogen atom) or a salt thereof, wherein the method comprises the following steps of (1″) to (3″):

(1″) reacting a compound represented by formula (IX)

(wherein, each of the two R 2 s represents a C 1-4 alkyl group, and the two R 2 s may be bonded to each other to form a cyclic group represented by —(CH 2 ) n — (wherein, n represents an integer of 2 to 4); Hal′″ represents a halogen atom) with morpholine to obtain a compound represented by formula (X)

(wherein, R 2 represents the same group as in formula (IX));

(2″) reacting a compound represented by formula (X) with a halogenating reagent to obtain a compound represented by formula (XI)

(wherein, R 2 represents the same group as in formula (IX), and Hal″ represents a halogen atom);

(3″) performing a deketalization reaction on a compound represented by formula (XI) to obtain a morpholine-substituted phenacyl derivative (B) represented by formula (VIII) (In the above formulas, Me represents a methyl group).

12. The method of claim 11 , wherein the compound represented by formula (IX)

(wherein, each of the two R 2 s represents a C 1-4 alkyl group, and the two R 2 s may be bonded to each other to form a cyclic group represented by —(CH 2 ) n — (wherein, n represents an integer of 2 to 4, and Me represents a methyl group); Hal′″ represents a halogen atom) is obtained through the steps of: ketalization of a compound represented by formula (XII)

(wherein, Hal″″ represents a halogen atom), by reacting with R 2 OH, HC(OR 2 ) 3 (wherein R 2 represents a C 1-4 alkyl group), or HO—(CH 2 ) n —OH (wherein, n represents an integer of 2 to 4); and methoxylation of the hydroxyl group in the compound represented by formula (XII).

13. A method for recrystallizing a cyclic benzamidine derivative (C), wherein the method comprises the steps of dissolving a compound represented by formula (XIII)

(wherein, Me represents a methyl group, and Et represents an ethyl group)), or the salt thereof, in a mixed solvent comprising an alcohol and water, or a mixed solvent comprising an ether and water; and

after dissolution, adding additional water to precipitate crystals of the compound represented by formula (XIII)), or the salt thereof.

14. The recrystallization method of claim 13 , wherein the mixed solvent is a mixed solvent comprising an alcohol and water.

15. A compound represented by formula (XIV)

(wherein, R 3 represents a halogen atom or CN; R 4 represents a hydrogen atom, a methyl group, —CHO, —CH 2 OH, —CH 2 Hal (wherein, Hal represents a halogen atom), —CH 2 —OSO 2 R 1 (wherein, R 1 represents a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 6-10 aryl group, or a halogenated C 6-10 aryl group), a phthalimide methyl group, or a succinimide methyl group; and Et represents an ethyl group).

16. A compound represented by formula (XV)

(wherein, each of the two R 2 s represents an alkyl group of 1-4 carbon atoms, and the two R 2 s may be bonded to each other to form a cyclic group represented by —(CH 2 ) n — (wherein, n represents an integer of 2 to 4); R 5 represents a hydrogen atom or a halogen atom, R 6 represents a halogen atom or a morpholino group, and Me represents a methyl group), or a salt thereof.

17. The method of claim 7 , wherein the compound represented by formula (III) is obtained by steps comprising the following (1) to (3):

(1) reacting a compound represented by formula (V)

(wherein, Hal′ represents a halogen atom) with a cyanation reagent to obtain a compound represented by formula (VI)

(2) obtaining a compound represented by formula (VII)

through a formylation reaction of the compound represented by formula (VI); and

(3) obtaining the compound represented by formula (III)

(wherein, Et represents an ethyl group) by reducing the compound represented by formula (VII).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019265/0447 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2005
From: SHIMOMURA, NAOYUKI; SASHO, MANABU; KAYANO, AKIO; YOSHIZAWA, KAZUHIRO; TSUJII, MASAHIKO; KURODA, HIROSHI; FURUKAWA, KEN
To: EISAI CO., LTD.
Reel/Frame 016820/0767 →
Priority Claims (1)
JP 2003-040949 · Feb 19, 2003 · national
Continuity (2)
Continuation In Part PCTJP0400139600 · Feb 10, 2004
Related Publication 20060058370A1 · Mar 16, 2006